ATM and neoplasm: Combination of olaparib with a lower dose of AZD7648 (37.5 mg kg−1 bid × 53 days) in FaDu ATM KO xenografts also induced effective tumour regression, albeit with a delay compared with the higher dose (Fig. 5c).